NL8102178A - Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. - Google Patents
Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. Download PDFInfo
- Publication number
- NL8102178A NL8102178A NL8102178A NL8102178A NL8102178A NL 8102178 A NL8102178 A NL 8102178A NL 8102178 A NL8102178 A NL 8102178A NL 8102178 A NL8102178 A NL 8102178A NL 8102178 A NL8102178 A NL 8102178A
- Authority
- NL
- Netherlands
- Prior art keywords
- antigen
- reagent
- antibodies
- insoluble
- antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 55
- 108091007433 antigens Proteins 0.000 title claims abstract description 54
- 102000036639 antigens Human genes 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 34
- 238000012360 testing method Methods 0.000 claims abstract description 10
- 230000003993 interaction Effects 0.000 claims abstract description 8
- 210000002966 serum Anatomy 0.000 claims abstract description 8
- 239000012456 homogeneous solution Substances 0.000 claims abstract description 6
- 210000001124 body fluid Anatomy 0.000 claims abstract description 3
- 239000010839 body fluid Substances 0.000 claims abstract description 3
- 238000000338 in vitro Methods 0.000 claims abstract description 3
- 210000002381 plasma Anatomy 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 108090001008 Avidin Proteins 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 5
- 235000020958 biotin Nutrition 0.000 claims description 5
- 239000011616 biotin Substances 0.000 claims description 5
- 230000001376 precipitating effect Effects 0.000 claims description 5
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 125000001894 2,4,6-trinitrophenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 239000003708 ampul Substances 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract 1
- 229940046528 grass pollen Drugs 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 229920002684 Sepharose Polymers 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- HVGAOLHAWVNIQU-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;pyrrolidine-2,5-dione Chemical compound O=C1CCC(=O)N1.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 HVGAOLHAWVNIQU-UFLZEWODSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000004579 marble Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229960004784 allergens Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940043515 other immunoglobulins in atc Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8102178A NL8102178A (nl) | 1981-05-02 | 1981-05-02 | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. |
| US06/373,644 US4468470A (en) | 1981-05-02 | 1982-04-30 | Method and a kit for the assay of antibodies to soluble antigens |
| CA000402054A CA1177391A (en) | 1981-05-02 | 1982-04-30 | Method and a kit for the assay of antibodies to soluable antigens |
| IE1027/82A IE53059B1 (en) | 1981-05-02 | 1982-04-30 | A method and a kit for the assay of antibodies to soluble antigens |
| ES512498A ES8304314A1 (es) | 1981-05-02 | 1982-04-30 | "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles". |
| DE8282200517T DE3265768D1 (en) | 1981-05-02 | 1982-04-30 | A method and a kit for the assay of antibodies to soluble antigens |
| EP82200517A EP0064318B1 (en) | 1981-05-02 | 1982-04-30 | A method and a kit for the assay of antibodies to soluble antigens |
| AU83174/82A AU8317482A (en) | 1981-05-02 | 1982-04-30 | Assay of antibodies to soluble antigens |
| AT82200517T ATE15274T1 (de) | 1981-05-02 | 1982-04-30 | Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene. |
| NO821431A NO160474C (no) | 1981-05-02 | 1982-04-30 | Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener. |
| DK196282A DK155967C (da) | 1981-05-02 | 1982-04-30 | Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener |
| JP57071591A JPS589071A (ja) | 1981-05-02 | 1982-04-30 | 抗体検定方法および抗体検定用試薬 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8102178A NL8102178A (nl) | 1981-05-02 | 1981-05-02 | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. |
| NL8102178 | 1981-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8102178A true NL8102178A (nl) | 1982-12-01 |
Family
ID=19837436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8102178A NL8102178A (nl) | 1981-05-02 | 1981-05-02 | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4468470A (ja) |
| EP (1) | EP0064318B1 (ja) |
| JP (1) | JPS589071A (ja) |
| AT (1) | ATE15274T1 (ja) |
| AU (1) | AU8317482A (ja) |
| CA (1) | CA1177391A (ja) |
| DE (1) | DE3265768D1 (ja) |
| DK (1) | DK155967C (ja) |
| ES (1) | ES8304314A1 (ja) |
| IE (1) | IE53059B1 (ja) |
| NL (1) | NL8102178A (ja) |
| NO (1) | NO160474C (ja) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3225027A1 (de) * | 1982-07-05 | 1984-01-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Immunchemisches messverfahren |
| GB8422452D0 (en) * | 1984-09-05 | 1984-10-10 | Serono Diagnostics Ltd | Assay |
| US4806311A (en) * | 1985-08-28 | 1989-02-21 | Miles Inc. | Multizone analytical element having labeled reagent concentration zone |
| US5262334A (en) * | 1986-01-30 | 1993-11-16 | Fred Hutchinson Cancer Research Center | Method for immunoselection of cells using avidin and biotin |
| US5225353A (en) * | 1986-01-30 | 1993-07-06 | Fred Hutchinson Cancer Research Center | Method for immunoselection of cells using avidin and biotin |
| JP2505179B2 (ja) * | 1986-12-16 | 1996-06-05 | 日本碍子株式会社 | 高強度常圧焼結窒化珪素焼結体およびその製造方法 |
| US4859612A (en) * | 1987-10-07 | 1989-08-22 | Hygeia Sciences, Inc. | Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite |
| US5202267A (en) * | 1988-04-04 | 1993-04-13 | Hygeia Sciences, Inc. | Sol capture immunoassay kit and procedure |
| DE4140142A1 (de) * | 1991-12-05 | 1993-06-09 | Boehringer Mannheim Gmbh, 6800 Mannheim, De | Multivalentes dextranreagenz zum einsatz in praezipitationstests |
| US5518882A (en) * | 1993-12-21 | 1996-05-21 | Biotex Laboratories, Inc. | Immunological methods of component selection and recovery |
| FR2716263B1 (fr) * | 1994-02-11 | 1997-01-17 | Pasteur Institut | Procédé d'alignement de macromolécules par passage d'un ménisque et applications dans un procédé de mise en évidence, séparation et/ou dosage d'une macromolécule dans un échantillon. |
| DE4434093A1 (de) * | 1994-09-23 | 1996-03-28 | Boehringer Mannheim Gmbh | Verfahren zum qualitativen oder/und quantitativen Nachweis einer zu bestimmenden Substanz |
| US5773224A (en) * | 1996-02-12 | 1998-06-30 | Grandics; Peter | Immunoselection system for cell elution |
| US6436722B1 (en) * | 2000-04-18 | 2002-08-20 | Idexx Laboratories, Inc. | Device and method for integrated diagnostics with multiple independent flow paths |
| EP1195606A1 (en) * | 2000-10-03 | 2002-04-10 | VBC-Genomics Forschungsges.m.b.H. | Allergen-microarray assay |
| ATE538380T1 (de) * | 2001-01-23 | 2012-01-15 | Harvard College | Nukleinsäure-programmierbare protein-arrays |
| DE10327066A1 (de) * | 2002-11-29 | 2004-09-16 | Max-Delbrück-Centrum für Molekulare Medizin | Bestimmung agonistischer Autoantikörper |
| US7741050B2 (en) * | 2002-11-29 | 2010-06-22 | Max-Delbrueck-Centrum fuer Molkulare Medizin | Identification of agonistic autoantibodies |
| WO2005108615A2 (en) * | 2004-04-14 | 2005-11-17 | President And Fellows Of Harvard College | Nucleic-acid programmable protein arrays |
| US8178316B2 (en) * | 2006-06-29 | 2012-05-15 | President And Fellows Of Harvard College | Evaluating proteins |
| WO2017087798A1 (en) | 2015-11-18 | 2017-05-26 | Formycon Ag | Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE341239B (ja) * | 1967-09-06 | 1971-12-20 | Pharmacia Ab | |
| US3773625A (en) * | 1971-04-08 | 1973-11-20 | Us Army | Soluble antigen-antibody complexes |
| US3966898A (en) * | 1973-06-28 | 1976-06-29 | Pharmacia Diagnostics Ab | Method and reagent for determining immunologic materials |
| US4230797A (en) * | 1975-04-28 | 1980-10-28 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a coenzyme as label |
| US4021534A (en) * | 1975-12-12 | 1977-05-03 | Hoffmann-La Roche Inc. | Radioimmunoassay |
| SE427505B (sv) * | 1977-03-04 | 1983-04-11 | Pharmacia Diagnostics Ab | Reagens till anvendning vid immunkemiska bestemningsmetoder |
| IL51667A (en) * | 1977-03-16 | 1979-10-31 | Miles Yeda Ltd | Immunoassay for the determination of a hapten |
| US4271140A (en) * | 1978-01-23 | 1981-06-02 | Baxter Travenol Laboratories, Inc. | Method and composition for double receptor, specific binding assays |
| JPS5510590A (en) * | 1978-05-04 | 1980-01-25 | Wellcome Found | Enzyme immunity quantity analysis |
| US4228237A (en) * | 1978-09-21 | 1980-10-14 | Calbiochem-Behring Corp. | Methods for the detection and determination of ligands |
| US4495296A (en) * | 1979-05-21 | 1985-01-22 | New York Blood Center, Inc. | Labeled anti-hapten antibodies and their use as a universal reagent for solid phase radio- and/or enzyme-immunoassays |
-
1981
- 1981-05-02 NL NL8102178A patent/NL8102178A/nl not_active Application Discontinuation
-
1982
- 1982-04-30 AU AU83174/82A patent/AU8317482A/en not_active Abandoned
- 1982-04-30 EP EP82200517A patent/EP0064318B1/en not_active Expired
- 1982-04-30 AT AT82200517T patent/ATE15274T1/de active
- 1982-04-30 NO NO821431A patent/NO160474C/no unknown
- 1982-04-30 IE IE1027/82A patent/IE53059B1/en unknown
- 1982-04-30 US US06/373,644 patent/US4468470A/en not_active Expired - Lifetime
- 1982-04-30 DK DK196282A patent/DK155967C/da not_active IP Right Cessation
- 1982-04-30 JP JP57071591A patent/JPS589071A/ja active Pending
- 1982-04-30 DE DE8282200517T patent/DE3265768D1/de not_active Expired
- 1982-04-30 CA CA000402054A patent/CA1177391A/en not_active Expired
- 1982-04-30 ES ES512498A patent/ES8304314A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES512498A0 (es) | 1983-02-16 |
| JPS589071A (ja) | 1983-01-19 |
| DE3265768D1 (en) | 1985-10-03 |
| AU8317482A (en) | 1982-11-11 |
| DK155967C (da) | 1989-10-16 |
| EP0064318B1 (en) | 1985-08-28 |
| DK196282A (da) | 1982-11-03 |
| NO160474B (no) | 1989-01-09 |
| NO821431L (no) | 1982-11-03 |
| US4468470A (en) | 1984-08-28 |
| CA1177391A (en) | 1984-11-06 |
| NO160474C (no) | 1989-04-19 |
| EP0064318A1 (en) | 1982-11-10 |
| IE53059B1 (en) | 1988-05-25 |
| ATE15274T1 (de) | 1985-09-15 |
| DK155967B (da) | 1989-06-05 |
| ES8304314A1 (es) | 1983-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8102178A (nl) | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. | |
| US4298685A (en) | Diagnostic reagent | |
| CA1149277A (en) | Process for determining immuno-complexes | |
| CA1341592C (en) | Ion capture reagents and methods for performing binding assays | |
| EP0525034B1 (en) | Antigen/anti-antigen cleavage | |
| FI102921B (fi) | Menetelmä biologisesti aktiivisten reagenssien valmistamiseksi sukkiin i-imidiä sisältävistä polymeereistä, analyysielementti ja menetelmiä n iiden käyttämiseksi | |
| EP0014530B1 (en) | Method for detecting and determining proteinaceous specific binding agents and materials bindable thereto, test composition and testkit therefor | |
| JPH06508687A (ja) | 可溶性ｈｌａクロス−マッチ | |
| JPS60501129A (ja) | 強化凝集分析法及びその試剤 | |
| Costello et al. | Enhancement of immune cellular agglutination by use of an avidin-biotin system. | |
| CA2046130A1 (en) | Biologically active reagent, analytical element and methods for use of the reagent | |
| Witkin et al. | Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum. | |
| EP0108992B1 (en) | Immunoassay | |
| AU625344B2 (en) | Chlamydia half-sandwich immunoassay | |
| US5637472A (en) | Hydrazine derivatized cells | |
| JPS58144749A (ja) | 第２抗体で被覆したイムノアツセイ用プラスチツク支持材およびその製造方法 | |
| JP3657015B2 (ja) | 免疫反応測定用試薬キット | |
| JP3073501B2 (ja) | Ｃ―反応性タンパクの修飾形態による免疫複合体の結合 | |
| CA2110159A1 (en) | Technique for prevention of false positive reactions in immunological testing | |
| JPS59214767A (ja) | ヒト妊娠特異蛋白測定用キツト | |
| JPS5861466A (ja) | 血清学的凝集反応による測定方法 | |
| JPH08233819A (ja) | 感作標識担体、抗原又は抗体の検出方法及び検出用検査セット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1B | A search report has been drawn up | ||
| A85 | Still pending on 85-01-01 | ||
| BC | A request for examination has been filed | ||
| BI | The patent application has been withdrawn |